Health Care

Novartis plans to cut 2,100 jobs in Switzerland, Britain

Novartis said Tuesday it's cutting some 2,100 jobs in Switzerland and Britain over several years as the Swiss pharmaceuticals giant tweaks its corporate structure to become more nimble and more efficient.

Groups say Medicare discounts threatened in opioids bill

Consumer and health care groups say they're trying to block the pharmaceutical industry from commandeering opioid legislation and using it to roll back drugmaker discounts to Medicare beneficiaries with high prescription costs.

Biopharmaceutical company fined for misleading investors

A Colorado-based biopharmaceutical company has been penalized more than $20 million for misleading investors about the efficacy of a lung cancer drug under development before raising $300 million in a public stock offering.

Canadian marijuana imports OK'd by US for California study

In a rare move, the U.S. government has approved the importation of marijuana extracts from Canada for a clinical trial, highlighting a new avenue for American researchers who have long had trouble obtaining the drug for medical studies.